Papaseit E - Search Results

1

Papaseit E, Pérez-Mañá C, Pérez-Acevedo AP, Hladun O, Torres-Moreno MC, Muga R, Torrens M, Farré M. Papaseit E, et al. Int J Med Sci. 2018 Aug 6;15(12):1286-1295. doi: 10.7150/ijms.27087. eCollection 2018. Int J Med Sci. 2018. PMID: 30275754 Free PMC article. Review.

2

Development and validation of a liquid chromatography-tandem mass spectrometry assay for hair analysis of atomoxetine and its metabolites: Application in clinical practice.

Papaseit E, Marchei E, Mortali C, Aznar G, Garcia-Algar O, Farrè M, Pacifici R, Pichini S. Papaseit E, et al. Forensic Sci Int. 2012 May 10;218(1-3):62-7. doi: 10.1016/j.forsciint.2011.10.012. Epub 2011 Oct 22. Forensic Sci Int. 2012. PMID: 22024657

3

Surviving life-threatening MDMA (3,4-methylenedioxymethamphetamine, ecstasy) toxicity caused by ritonavir (RTV).

Papaseit E, Vázquez A, Pérez-Mañá C, Pujadas M, de la Torre R, Farré M, Nolla J. Papaseit E, et al. Intensive Care Med. 2012 Jul;38(7):1239-40. doi: 10.1007/s00134-012-2537-9. Epub 2012 Mar 30. Intensive Care Med. 2012. PMID: 22460853 No abstract available.

4

Concentrations of atomoxetine and its metabolites in plasma and oral fluid from paediatric patients with attention deficit/hyperactivity disorder.

Papaseit E, Marchei E, Farré M, Garcia-Algar O, Pacifici R, Pichini S. Papaseit E, et al. Drug Test Anal. 2013 Jun;5(6):446-52. doi: 10.1002/dta.1370. Epub 2012 May 16. Drug Test Anal. 2013. PMID: 22589233

5

[Methylphenidate in the treatment of children with attention-deficit hyperactivity disorder: monitoring in biological matrices].

Papaseit E, García-Algar O, Simó S, Pichini S, Farré M. Papaseit E, et al. An Pediatr (Barc). 2013 Feb;78(2):123.e1-10. doi: 10.1016/j.anpedi.2012.08.015. Epub 2012 Oct 10. An Pediatr (Barc). 2013. PMID: 23063334 Free article. Spanish.

6

[Thalidomide: an unfinished history].

Papaseit E, García-Algar O, Farré M. Papaseit E, et al. An Pediatr (Barc). 2013 May;78(5):283-7. doi: 10.1016/j.anpedi.2012.11.022. Epub 2013 Jan 16. An Pediatr (Barc). 2013. PMID: 23333198 Free article. Spanish. No abstract available.

7

[Abuse-related adverse drug reactions and abuse deterrent formulations].

Papaseit E, Pérez-Mañá C, Torrens M, Farré M. Papaseit E, et al. Med Clin (Barc). 2013 Nov 16;141(10):454-8. doi: 10.1016/j.medcli.2013.09.008. Epub 2013 Oct 19. Med Clin (Barc). 2013. PMID: 24144061 Review. Spanish. No abstract available.

8

Bilastine vs. hydroxyzine: occupation of brain histamine H1 -receptors evaluated by positron emission tomography in healthy volunteers.

Farré M, Pérez-Mañá C, Papaseit E, Menoyo E, Pérez M, Martin S, Bullich S, Rojas S, Herance JR, Trampal C, Labeaga L, Valiente R. Farré M, et al. Among authors: papaseit e. Br J Clin Pharmacol. 2014 Nov;78(5):970-80. doi: 10.1111/bcp.12421. Br J Clin Pharmacol. 2014. PMID: 24833043 Free PMC article. Clinical Trial.

9

Emerging drugs in Europe.

Papaseit E, Farré M, Schifano F, Torrens M. Papaseit E, et al. Curr Opin Psychiatry. 2014 Jul;27(4):243-50. doi: 10.1097/YCO.0000000000000071. Curr Opin Psychiatry. 2014. PMID: 24840157 Review.

10

Evaluation of the reporting level to detect triamcinolone acetonide misuse in sports.

Matabosch X, Pozo OJ, Pérez-Mañá C, Papaseit E, Marcos J, Segura J, Ventura R. Matabosch X, et al. Among authors: papaseit e. J Steroid Biochem Mol Biol. 2015 Jan;145:94-102. doi: 10.1016/j.jsbmb.2014.09.018. Epub 2014 Sep 24. J Steroid Biochem Mol Biol. 2015. PMID: 25260353

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

87 results

Search Page